Strategy
-
Making Russia a global leader of the biotechnology market. -
Development of new standards of creation of innovative products in the field of biotechnology in Russia and in the global markets. -
Expansion of innovative domestic products and services to the world markets
Development strategies
-
10 research projects on the development of modern "end-to-end" biotechnologies for production of active pharmaceutical substances to treat different socially significant diseases being at various R&D stages. The projects have been merged into a single platform that allows to approach the development of essential products and technologies with national importance. Additional business competencies in the field of pharmaceutical production (Generium) and academic and training centers are involved in the implementation of R&D projects for the instrument design of the developed platforms (a total of 28 member organizations of the Consortium)
-
1 project on preclinical trials of active biomolecules in accordance with the standards of good laboratory Practice (GLP) and the requirements of the OECD standards (Organization for economic cooperation and development)
-
1 project development of modern technologies for keeping / breeding laboratory rabbits SPF-category and the creation of new animals-biomodels pathological conditions of the human body, designed to find new drugs
-
1 educational project project aimed at training modern professionals in the field of biotechnology and pharmaceutical technology. It includes 5 modules of training, is closely linked to the areas of implementation of "end-to-end" biotechnology and NTI markets.